Congress passes sweeping user fee reauthorization bill to fund increased FDA staffing and support commitments to product review timelines.
Key Points:
..Congress authorized FDA to collect increased total annual user fees for all product categories compared to previous user fee authorization programs.
..The bill also includes other provisions designed to expand access to generic drugs and products targeting life-threatening pediatric or rare diseases or conditions, and to improve the inspection process, among other goals.
Please see full publication below for more information.
